Is Compounded Semaglutide Still Available in 2026?

If you have been searching to find out whether compounded semaglutide is still available, coming back, or banned in 2026, here is the honest short answer. As of mid-2026, compounded GLP-1 medications remain available to eligible patients through some licensed providers and US-based compounding pharmacies, but the regulatory landscape is still evolving and continued availability is not guaranteed. That means it is reasonable to get evaluated now, understand your options, and have a plan rather than waiting and worrying.

The short answer

Yes, for now, eligible patients can still access compounded GLP-1 medications. No, that access is not promised to last forever, and no, there has not been an outright ban.

If you are reading this because you saw a headline about the FDA and compounded GLP-1, take a breath. The situation is more specific than “it is gone.” What actually happened is a change in the legal basis for large-scale compounding, not a switch being flipped off overnight. Some pharmacies have stepped back, others continue, and the practical answer to “can I still get it” depends on the pharmacy, your state, and a provider’s evaluation of your health history.

The rest of this page walks through what changed, what it means for availability right now, whether you can still start today, and what to do if access gets harder later.

What changed: the end of the shortage

Compounded GLP-1 medications became widely available because of a specific situation. When demand for semaglutide and tirzepatide outpaced supply, the FDA listed them on its drug shortage list, and federal law allowed licensed compounding pharmacies to prepare versions of medications that appear on that list.

In early 2025, that changed. The FDA removed semaglutide from the shortage list, and tirzepatide followed. Once a medication comes off the shortage list, the broad legal basis that allowed large-scale compounding shifts. The exemption that made it straightforward for big outsourcing facilities to prepare these medications in bulk no longer applied the same way.

This is the part that gets compressed into scary headlines. The shortage ending is real, and it genuinely changed the rules. But “the rules changed” is not the same as “compounded GLP-1 is illegal now.” For the full legal picture, including the difference between 503A and 503B pharmacies and what the FDA’s enforcement timeline actually looked like, see our companion guide on compounded GLP-1 after the shortage. This page stays focused on the practical question.

What that means for availability right now

Here is the practical reality as of mid-2026.

Patient-specific compounding by state-licensed pharmacies continues in some circumstances, when an independent provider writes a prescription for an individual patient. That is a different legal framework from the bulk preparation that the shortage exemption enabled, and it has not simply disappeared.

At the same time, availability is uneven. It varies by pharmacy and by state. Some compounders have stopped preparing GLP-1 medications entirely. Others continue. State pharmacy boards, federal guidance, and ongoing legal questions are all part of the picture, and they are not all moving in the same direction at the same speed. The honest way to describe it is that the landscape is fragmenting rather than holding steady.

What that means for you is simple. You cannot assume that what one person could get six months ago in one state is what you can get today in yours. The only way to know your real, current options is to be evaluated by a licensed provider who works with US-based, licensed pharmacies and can tell you what is actually available right now.

Can you still start today?

Yes. As of mid-2026, eligible patients can still begin a compounded GLP-1 program through an online evaluation. The path is the same one we use for any patient, and it is built around a provider making the clinical call, not a checkout button.

Here is what starting actually looks like:

• You complete an online intake covering your health history, current medications, and goals. It takes about 10 minutes.
• An independent, licensed provider reviews your information and determines whether a prescription is medically appropriate for you. Transformation Health does not prescribe, and a prescription is never guaranteed.
• If a prescription is appropriate, your medication is prepared by a US-based, state-licensed compounding pharmacy and shipped to you, and your coaching and labs are part of the program.
• Residents of AR, DC, DE, MS, NM, RI, and WV are required by state law to complete a live video consultation before a prescription can be written.

Not all patients qualify, and the provider’s evaluation is genuine, not a formality. You can read more about how the online evaluation works on our page about getting a GLP-1 prescription online.

What to do if it becomes harder to get later

Because continued availability is not something anyone can honestly promise, the smart move is to understand your backup options now, before you need them. If compounded access becomes harder where you live, you are not out of choices.

Start by working with your provider. They can tell you what is currently available and help you think through what makes sense for your situation if your current option changes. This is exactly the kind of conversation an ongoing provider relationship is for.

Understand maintenance and microdosing approaches. If you have already made progress, some patients are able to maintain results on a lower dose or at extended intervals where that remains available. Your provider can explain whether that fits your goals.

Be aware of brand-name routes as a backup. Some insurance plans now cover brand-name GLP-1 medications for weight management, not only for diabetes or cardiovascular indications, and coverage has been expanding. For patients without coverage, manufacturer patient-assistance programs may help if you income-qualify. Our overview of savings and assistance programs walks through these paths.

None of these is a perfect substitute for everyone, and we are not telling you that compounded GLP-1 is interchangeable with a brand-name product. The point is that having a plan beats being caught off guard.

How Transformation Health approaches this

We work only with US-based, state-licensed compounding pharmacies. We do not use offshore sources or facilities with compliance problems, and every prescription requires evaluation by an independent, licensed provider.

We also watch FDA guidance closely, because the ground is moving and we would rather adjust than pretend it is not. If a pharmacy we work with steps back from GLP-1 preparation, we work with providers to help patients understand their options, whether that means a maintenance approach, a brand-name route through insurance, or a patient-assistance program.

What we will not do is promise you that compounded GLP-1 will be available indefinitely. We cannot, and any company that tells you it can is not being straight with you. Availability of compounded GLP-1 medications is subject to FDA drug shortage-list status and applicable state and federal pharmacy laws, which may change. We would rather you start with clear eyes than be surprised later.

Important disclosures

Compounded GLP-1 medications are not FDA-approved. They are prepared by US-based, state-licensed compounding pharmacies and have not been independently evaluated by the FDA for safety, efficacy, or quality. They are not the same as brand-name GLP-1 products, and nothing on this page should be read as claiming they are equivalent.

Transformation Health is a technology platform that connects patients with care. All clinical decisions are made by independent, licensed healthcare providers. A prescription is never guaranteed, not all patients qualify, and results vary by individual. Residents of AR, DC, DE, MS, NM, RI, and WV are required by state law to complete a live video consultation before a prescription can be written.

The regulatory status of compounded GLP-1 medications is evolving. This page reflects the situation as of mid-2026 and is for general educational purposes only. It is not legal or medical advice, and the availability described here may change. Talk with a licensed provider about your specific situation.